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Abstract
Background: Dengue, an acute febrile illness caused by infection with dengue virus (DENV), is endemic in Bali,
Indonesia. As one of the world’s most popular tourist destinations, Bali is regularly visited by domestic and inter-
national travellers, who are prone to infection by endemic pathogens, including DENV. Currently, limited data are avail-
able on the characteristics of dengue in travellers visiting Bali. Information on the epidemiology and virological aspects
of dengue in these tourists is important to gain a better understanding of the dengue disease in international travellers.
Methods: We performed a prospective cross-sectional dengue study involving foreign travellers visiting Bali,
Indonesia in the period of 2015–17. Patients presenting at Kasih Ibu Hospital with fever and clinical symptoms of
dengue were asked to participate in the study. Clinical and laboratory assessments were performed and sera were
collected for molecular analysis, which included DENV serotyping, genome sequencing and phylogenetic analysis.
Results: Among the 201 patients recruited, dengue was confirmed in 133 (66.2%) of them, based on detection of
NS1 antigen and/or viral RNA. Of these, 115 (86.5%) manifested dengue fever (DF) and 18 (13.5%) dengue haemor-
rhagic fever (DHF). The temporal predominance of infecting DENV serotype was DENV-2 (48.7%), followed by
DENV-3 (36.1%), DENV-1 (9.2%) and DENV-4 (3.4%). Phylogenetic analysis of DENV based on envelope gene
sequences revealed that the source of DENVs was local endemic viruses.
Conclusion: Our study confirms that dengue is one of the causes of fever in travellers visiting Bali. Although it is a
cause of significant morbidity, the majority of patients only experienced mild DF, with only a small proportion
developing DHF. We revealed that DENVs isolated were autochthonous. Accurate diagnosis, preventive measures
and continuous disease surveillance will be useful for better management of dengue infection in travellers.
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Introduction
Dengue disease poses a significant public health challenge, with
a global burden of 390 million infections occurring annually,
with 70% of the world population at risk.1 Four DENV sero-
types (DENV-1, -2, -3 and -4) circulate in tropical and subtrop-
ical regions of the world and are transmitted by the Aedes
mosquito vectors.2 DENV shows very high genetic diversity, as
demonstrated by the presence of four serotypes, within which
there are several clusters of variants, termed genotypes.3 Dengue
can be asymptomatic or clinically manifested as mild flu-like
syndrome, known as classic Dengue Fever (DF), or in a more
severe form known as Dengue Haemorrhagic Fever (DHF), to
the potentially fatal Dengue Shock Syndrome (DSS).4
The evolution of global travel patterns characterised by dra-
matic increases in travel primarily those from emerging econ-
omies5 is found to translate into different geographic dispersion
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patterns of infectious diseases.6 These include DF, where more
tourists visit dengue endemic countries7 and the consequence is
an increase in the number of cases in returning travellers.8
While travel-related morbidity data are available, most of the
data acquisition is still mainly driven by ‘Western countries’.6 It
is increasingly important to conduct research not only in the
receiving countries but also in the countries of acquisition where
dengue is endemic7 including Indonesia where there is lack of
data on exported dengue.
Indonesia is hyperendemic for dengue9 and classified as a
country with frequent/continuous risks of dengue infection for
visiting travellers in the dengue-risk map.10 The intensive labour
flow and a large number of travellers in Bali have been reported
to contribute to the spread of DENV infection.11 Previous
reports indicate the hyperendemic transmission of all four
DENV serotypes in Bali, where circulating DENVs include dom-
inant local strains, suggesting that Bali is a melting pot of sub-
stantial DENV diversity and serves as a hub for dengue
transmission and mixing of different strains.12–14
With the increase in a number of travellers in the coming
decades as well as significant overall growth in the tourism sec-
tor worldwide,5 it is important to obtain data on exported den-
gue in travellers visiting Bali. As a very popular tourist
destination, the endemicity of dengue in Bali can ultimately
impact the health of foreign visitors. However, currently there
are no data on dengue amongst travellers in Bali, including the
clinical spectrum and infecting DENV serotypes. The informa-
tion of whether travellers contract the disease locally or from
other regions that were visited before Bali could not be ascer-
tained. Molecular genotyping will be able to determine the
genotype of the viruses and to some extent may also be used to
track the origin of the viruses.15 Data on the clinical severity of
the dengue and DENV serotypes and genotypes in travellers are
important in order to gain comprehensive information on den-
gue disease in travellers. We conducted a fever survey, with the
main focus on foreign tourists showing symptoms of dengue
infection. The travellers were recruited from a local reference
hospital, their demographic and clinical data assessed, and sera
collected for the characterization of the infecting viruses, which
included the serotype, genotype and the origin of the DENV.
Materials and Methods
Study design
The study was a prospective cross-sectional involving inter-
national travellers/tourists visiting Bali, Indonesia. The study
protocol was approved by the Medical Research Ethic
Committee of Udayana University/Sanglah General Hospital,
Bali. Written informed consent was obtained from all subjects.
Patients admitted to Kasih Ibu Hospital, Denpasar, Bali,
Indonesia, were asked to participate in the study, and patient
recruitment took place from April 2015 to December 2017. We
recruited patients more than 1 year of age with a measured
body temperature of ≥38°C and with less than 120 h/5 days of
fever (acute phase), accompanied by at least one of the dengue
symptoms, such as headache, rash, myalgia, arthralgia or retro-
orbital pain.4 We excluded fever patients with clear symptoms
of upper respiratory tract infections and/or those clearly diag-
nosed as non-dengue or who were unwilling to participate.
Serological and laboratory analyses
Serum samples were tested using dengue NS1 antigen and IgG/
IgM serology rapid-tests (Standard Diagnostics, Korea) for den-
gue diagnosis. To determine the infection status of patients,
samples were further tested using Dengue Duo IgG and IgM
ELISA (Panbio, Alere, Australia) according to the manufac-
turer’s instructions. Common blood parameters such as haemo-
globin, haematocrit, erythrocytes, platelets and leucocytes were
documented. Determination of dengue severity was based on
the WHO-SEARO dengue guidelines.4
Viral RNA detection and DENV genotype analysis
The presence of virus nucleic acid was detected using RT-PCR.
Virus RNA was extracted from sera using QIAamp Viral RNA
mini kit (Qiagen, Hilden, Germany) or the MagNA Pure LC
Total Nucleic Acid kit and an automated MagNA Pure LC
nucleic acid extraction system (Roche, Mannheim, Germany).
The RT-PCR detection and serotyping were performed accord-
ing to the method described elsewhere.13
The dengue NS1 and RT-PCR-negative samples were also
tested for the presence of other arboviruses using pan-Flavivirus
(such as Japanese Encephalitis, West Nile and Zika viruses) and
pan-Alphavirus (such as the Chikungunya virus) RT-PCR
panels, employing methods described elsewhere.16
For DENV genotype analysis, we sequenced the region of
the envelope (E) protein, as described previously.17 Sequences
were aligned using MUSCLE and phylogenetic trees and were
inferred using the Maximum Likelihood method employing a
general-time reversible (GTR) algorithm with four gamma para-
meters, invariant sites and 1000 boot-straps. The analysis was
performed to determine the genotypes of the DENV according
to classification by Goncalvez et al.,18 Twiddy et al.,19 Lanciotti
et al.20 and Lanciotti et al.,21 for DENV-1, -2, -3 and -4,
respectively. The E gene sequences of DENV obtained in this
study have been deposited in the GenBank repository, with
accession numbers MH173159–MH173175 and MH178411–
MH178419.
Statistical analysis
Statistical analyses were performed using SPSS Version 18 (SPSS
Inc., Chicago, IL) and R-statistics (www.r-project.org). A prob-
ability value of P ≤ 0.05 was considered statistically significant.
Results
Dengue cases and diagnosis in foreign travellers
Between April 2015 and December 2017, a total of 201 dengue-
suspected foreign-traveller patients were enrolled. Dengue was
confirmed in 133 (66.2%) patients, using NS1 antigen detection
and/or viral nucleic acid detection by RT-PCR. The NS1 antigen
was positive in 127 out of the 201 (63.2%). DENV serotype
information was obtained for 119 out of the 133 (89.47%)
dengue-confirmed patients. The age of the enrolled patients ran-
ged from 15 to 78 (with a mean of 37 years old). In terms of
gender, we observed a relatively equal proportion between
males (43.6%) and females (56.4%). The majority (59.7%) of
patients were of primary infection status.
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The top five nationalities of the patients with confirmed dengue
cases were German (16.5%), Russian (14.3%), Dutch (13.5%),
Swedish (8.3%) and French (6.8%) (Figure 1). Other arboviruses
were not identified in DENV-negative samples (n = 68).
DENV serotype distribution
DENV serotyping using RT-PCR revealed the presence of all
four DENV serotypes in the foreign patients. The predominant
serotype was DENV-2 (48.7%), followed by DENV-3 (36.1%),
DENV-1 (9.2%) and DENV-4 (3.4%) (Figure 2). Three samples
were detected to have concurrent/mixed infection of DENV ser-
otypes, of which two patients were infected by DENV-1 &
DENV-2, and one by DENV-1 & DENV-4.
Patient clinical manifestations
Based on WHO-SEARO dengue clinical manifestation, we clas-
sified 115 (86.5%) patients as DF, while 18 (13.5%) patients
were DHF. Within the DHF group, one patient was classified as
DHF Grade III (DSS). No fatalities were reported. We observed
that the most common clinical manifestation were fever, myal-
gia and headache (Table 1). Other common symptoms of den-
gue such as malaise, loss of appetite, retro-orbital and joint
pain, were also observed in smaller proportion. Rash was prom-
inent in only 9.8% of the patients.
DENV genotype analysis
To determine the origin and genetic profile of the DENV infect-
ing Bali travellers, we performed a phylogenetic analysis. A total
of 26 representative DENV E gene sequences from all four sero-
types were successfully obtained and phylogenetic trees were
constructed. Four DENV-1 isolates were classified as Genotype
I according to classification by Goncalvez et al.18 (Figure 3).
The isolates were closely related to recent DENV strains isolated
from local Balinese patients13 and other cities in Indonesia.
Eight DENV-2 isolates obtained belonged to the Cosmopolitan
genotype, based on Twiddy et al.’s classification19 (Figure 4). A
close relationship between the isolates from local Bali strains and
other cities in Indonesia was also observed. Three lineages
furtherly generated within the Cosmopolitan genotype were
observed to form monophyletic clades with DENV strains from
Bali.
We successfully sequenced the E genes of 10 DENV-3 iso-
lates. All the isolates were grouped together into Genotype I fol-
lowing Lanciotti et al.’s classification20 (Figure 5). The isolates
were closely related to local strains from Bali and other cities in
Indonesia. In addition, further sub-genotype grouping was
formed, reflecting a total of three distinct lineages.
Four isolates of DENV-4 obtained from travellers to Bali
were classified as members of Genotype II, following Lanciotti
et al.21 (Figure 6). Among them, a relationship with local Bali
strains was observed for three isolates, while one showed a close
relationship with an older strain of DENV-4 from Indonesia
and a strain from Jakarta from 2010 (unpublished).
Discussion
We have previously reported the hyperendemicity of DENV in
local Balinese people.13 In this study, we performed a
surveillance of DENV in foreign travellers, and confirmed that
dengue is one of the causes of febrile illnesses in travellers. We
also screened the dengue-negative samples for other arboviral
diseases that are endemic or previously detected in Bali, such as
Japanese Encephalitis, Zika and Chikungunya virus infec-

































































Figure 1. Nationality of travellers involved in the study. Other national-
ities include Austrian (2), Hungarian (2), Finnish (2), Estonian (2), Indian
(1), Philippine (1), Lithuanian (1), Italian (1), New Zealander (1),
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Figure 2. DENV serotype distribution among travellers visiting Bali
2015–17.
Table 1. Clinical manifestations of 133 dengue-confirmed
travellers





Loss of appetite 86 64.7
Retro-orbital pain 86 64.7
Joint pain 55 41.4
Vomiting 27 20.3
Sore throat 25 18.8
Bleeding 19 14.3
Rash 13 9.8
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virus isolation; however, we did not detect any positive results.
The data demonstrate the important contribution of DENV
infection in travellers to Bali presenting with febrile illness.
During our study, all four DENV serotypes were detected
which further supports the hyperendemicity of dengue in Bali.
However, most patients in this study were infected with DENV-
2, in contrary to the dengue infection in local Balinese people in
2015, where DENV-3 was predominant.13 However, our results
are in line with data reported by Ernst et al.,12 which showed
the same predominance of DENV-2 in Australian travellers vis-
iting Bali in 2010. The predominance of DENV-2 was also
reported in other cities in Indonesia in 2012.25 Considering that
our samples were collected from 2015 to 2017, the results may
indicate a change in serotype predominance over time and






Figure 3. Phylogenetic tree and genotype classification of DENV-1 iso-
lates from travellers to Bali (red font) with other reference strains.










Figure 4. Phylogenetic tree and genotype classification of DENV-2 iso-
lates from travellers to Bali (red font) with other reference strains.
Bootstrap values of >50 are shown. The scale bar indicates nucleotide
substitutions per site. Arabic numbers in red font denote lineage
clustering.
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We assessed the infection status of the patients and found
that the majority (59.7%) of DENV infections were primary.
This was not unexpected, considering that the patients came
from countries where dengue is not commonly present
(Figure 1). We presume that they have contracted dengue for
the first time during their visit to Bali. The presence of remark-
ably high dengue-seropositive travellers (40.3%) in this study
may have implications for dengue vaccination programs in
international travellers. With travel-acquired dengue increasing,
a safe and efficacious vaccine might be beneficial to prevent den-
gue in travellers as well as to reduce the risk of introduction to
non-endemic countries.
In general, a relatively milder disease severity was observed,
with most of the patients categorized as having DF. Mild den-
gue is more frequently reported in travellers compared to people








Figure 5. Phylogenetic tree and genotype classification of DENV-3 iso-
lates from travellers to Bali (red font) with other reference strains.
Bootstrap values of >50 are shown. The scale bar indicates nucleotide




Figure 6. Phylogenetic tree and genotype classification of DENV-4 iso-
lates from travellers to Bali (red font) with other reference strains.
Bootstrap values of >50 are shown. The scale bar indicates nucleotide
substitutions per site.
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infection might be contributing to the mild disease manifest-
ation. However, in this study, a small proportion of patients
experiencing DHF was still observed.
To understand the origin of the DENV infecting travellers
visiting Bali, we employed phylogenetic analysis using E gene
sequences. Phylogenetic analysis based on partial and/or com-
plete genomic sequences has been successfully used to elucidate
the origins, genetic diversity, transmission dynamics and epi-
demic potential of DENV.15 Using this method, we identified
the DENV infecting travellers as Genotype I, Cosmopolitan
genotype, Genotype I and Genotype II, for DENV-1, DENV-2,
DENV-3 and DENV-4, respectively. Overall, the genetic profiles
of DENV in travellers to Bali were similar to the reported
strains of local Balinese.13 Similar to previous findings,13 we did
not find Genotype IV of DENV-1, which may indicate that this
older lineage of DENV-1 has been replaced by the more recent
Genotype I.26 Moreover, we observed a close relationship
between the isolates and local Bali strains, strains from other cit-
ies in Indonesia, as well as strains from imported cases from
Australia and the region. No DENV isolates were found to ori-
ginate from or related to countries outside Indonesia. Overall,
our study confirmed that only local endemic strains were
responsible for dengue infection in international travellers to
Bali, and supports the potential of Bali and Indonesia in general
as the source of dengue case importation to other countries.13,27
The study has several limitations. Our patient recruitment
was performed only in one hospital. However, the Kasih Ibu
Hospital is the reference hospital for expatriates and inter-
national travellers, therefore the study population should be
quite representative. In addition, only symptomatic dengue
patients were recruited; therefore, we may have underestimated
the true burden of dengue on international travellers. With
regard to the DENV genetic analysis, we only used E gene
sequences and a more in-depth evolutionary analysis using
whole DENV genome sequences may be needed to better char-
acterize the genetic make-up of DENV in travellers to Bali. We
also did not have access to data on travellers’ personal measures
on protection against mosquito bite (e.g. the use of mosquito-
repellent). Nevertheless, our study is the first to report the inci-
dence of dengue in travellers visiting Bali and to provide data
on the clinical spectrum, epidemiology and virological aspects
of the disease.
In conclusion, our study demonstrates that dengue infection
is one of the causes of febrile illness in travellers visiting the
island. Although affecting travellers’ health, the majority of
patients only experienced mild DF. All four DENV serotypes
were found to infect the travellers reflecting the hyperendemicity
of dengue in the region, which may favour the spread of DENV
to other countries through visiting travellers. Monitoring and
continuous dengue surveillance, supported by an accurate diag-
nosis of the disease and preventive measures, including vaccin-
ation, improving healthcare access for travellers, will benefit
travellers visiting endemic areas including Bali.
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